MINNEAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator and provider of one of the world's largest regulatory-grade, AI-ready Real-World Data (RWD) network announced today that Aaron Green, President and CEO, issued the following letter to shareholders and other stakeholders of the Company: Dear OneMedNet Shareholders, Partners, and Family, 2025 has been a year of focus for OneMedNet – focus on our platform, focus on our people, ...

Core Insights - OneMedNet Corporation has demonstrated significant engagement and commercial traction at the RSNA Annual Meeting, indicating strong interest from hospitals, imaging centers, and life sciences innovators in its iRWD™ platform powered by Palantir Foundry [1][2][5] Company Overview - OneMedNet is a leading provider of regulatory-grade, AI-ready Real-World Data (RWD) networks, leveraging over 2,130 healthcare sites to deliver insights that drive innovation in healthcare [6] - The company focuses on providing high-quality, multimodal datasets that support healthcare providers and life sciences organizations in research and product development [5][6] Market Validation - The RSNA 2025 event validated OneMedNet's strategy amid rising demand for regulatory-grade RWD, with healthcare providers expressing a strong interest in utilizing their clinical data assets [2][3] - Life sciences companies and AI developers showed keen interest in the next-generation iRWD™ platform, highlighting its capabilities in providing large-scale, high-fidelity datasets and AI-enabled cohort discovery [4][5] Strategic Partnerships - Healthcare providers are looking for reliable and low-effort ways to engage in healthcare innovation and research, while life sciences organizations require scalable datasets to accelerate product development [5] - OneMedNet's efficient deployment model and opportunities for compliant data sharing were noted as key advantages for potential partners [3][5]

Core Insights - OneMedNet Corporation has expanded its Cardiovascular network by adding 85 new cardiovascular centers and data sources, positioning itself as one of the largest providers of Cardiovascular Real-World Data (RWD) [1][5] Industry Context - Cardiovascular diseases (CVDs) are the leading cause of death globally, responsible for approximately 19.8 million deaths in 2022, which accounts for about 32% of all global mortality [2] - The economic burden of CVD is significant, driving an estimated $320 billion annually in the United States and over $1 trillion globally in direct healthcare costs and lost productivity [2] Company Positioning - The enriched multimodal cardiovascular data network of OneMedNet is well-suited for the pharmaceutical and insurance sectors, providing real-time data that offers deeper insights into disease progression, treatment responses, and outcomes [3] - The expansion enhances OneMedNet's ability to deliver de-identified cardiovascular imaging, diagnostic reports, and electrocardiograms (ECG) at an unprecedented scale, continually updated to reflect the latest clinical insights [4][6] - OneMedNet is positioned as the premier source for high-quality, regulatory-grade cardiovascular RWD, which fuels innovation, supports clinical evidence generation, and improves patient outcomes [5] Technological Advancements - By combining de-identified cardiovascular imaging, structured reports, and ECG signals, OneMedNet provides real-world clinical insights that accelerate innovation in diagnostics, therapeutics, and AI model development [6] - The company utilizes its iRWD™ platform to harness the potential of over 1,750 healthcare sites, delivering precision insights across various medical fields, including cardiology [7]

Core Insights - OneMedNet Corporation reported significant improvements in its financial results for Q2 2025, highlighting a stronger balance sheet and operational advancements [1][4]. Financial Highlights - Total liabilities decreased from $19.7 million as of December 31, 2024, to $6.2 million as of June 30, 2025, marking a reduction of approximately $13.5 million, or about 80% [8]. - The company achieved net income of $3.0 million for Q2 2025, with other income of $5.0 million attributed to discounted debt settlements and conversions [8]. - OneMedNet successfully completed $3.7 million in private placements, including $1.2 million from insiders, to support sales execution and platform expansion [8]. Operational Highlights - The company expanded its provider network to 1,750 healthcare sites, now offering access to 136 million clinical studies [8]. - OneMedNet enhanced its iRWD™ platform capabilities, improving AI-driven de-identification, federated search, and multi-modal data integration [8]. - The company maintains a strategic digital asset position of 15 BTC valued at $1.6 million as of June 30, 2025 [8]. Strategic Focus - OneMedNet is committed to leveraging its improved balance sheet and strong sales funnel to pursue strategic opportunities that deliver long-term value to customers, partners, and shareholders [4]. - The company aims to revolutionize the use of Real-World Data (RWD) across various industries, including healthcare, finance, retail, and telecom, by harnessing the potential of its iRWD™ platform [5][6].

Core Viewpoint - OneMedNet Corporation has successfully raised approximately $3.7 million through private placement transactions at a price of $0.42 per share, with participation from the company's founders and directors [1][2]. Financial Actions - The proceeds from the private placements will be utilized for working capital and general corporate purposes [2]. - The company has achieved a 60% reduction in total liabilities, settling or converting approximately $11.0 million of current liabilities as of March 31, 2025 [3]. - Specific financial actions include settling approximately $3.26 million of deferred underwriter fees, $1.08 million in trade payables, and converting $6.56 million of principal and interest into common stock [8]. Company Overview - OneMedNet is a leader in providing regulatory-grade imaging Real-World Data (iRWD), leveraging data from over 1,400 healthcare sites to drive innovation in healthcare [6]. - The company’s iRWD™ platform supports advancements in various medical fields, including rare diseases, oncology, and cardiology, by delivering precision insights [6]. - Beyond healthcare, OneMedNet's proprietary AI technology anonymizes data for other industries such as finance, retail, and telecom, enhancing data security and project de-risking [7].

Core Insights - HealthVerity has integrated Premier, Inc. into its Marketplace, enhancing access to high-quality healthcare data for life sciences organizations [1][6] - The HealthVerity Marketplace is the largest verified healthcare and consumer data ecosystem in the U.S., providing insights from over 340 million de-identified individuals [2][4] - The partnership allows users to access inpatient and outpatient electronic medical record (EMR) data, including unstructured clinical notes, improving research capabilities [3][4] Company Overview - HealthVerity specializes in privacy-compliant real-world data exchange, supporting applications in clinical development, commercial strategy, and regulatory decision-making [7] - Premier, Inc. is a technology-driven healthcare improvement company serving two-thirds of U.S. healthcare providers, focusing on integrated data and analytics [8] Data Utilization - The Premier Healthcare Database (PHD) is a comprehensive repository for electronic healthcare data, aiding in the analysis of device and drug utilization, resource use trends, and care quality [4][6] - The partnership enhances the longitudinal view of patient journeys, measuring therapy effectiveness, quality, and cost [6]

Core Insights - OneMedNet Corporation has expanded its capabilities within the Datavant Connect platform to enhance healthcare data discovery, analytics, and partner assessment processes, emphasizing the importance of secure and scalable data solutions in healthcare innovation [1][4] - The healthcare industry is generating vast amounts of health-related data, which is often fragmented and siloed, creating challenges in accessibility and usability [2][5] - OneMedNet will utilize AWS Clean Rooms to provide secure collaboration environments for data partner assessment, enhancing data security and privacy without direct data movement [3][4] Company Overview - OneMedNet is a leader in providing regulatory-grade imaging Real-World Data (iRWD), leveraging over 1,400 healthcare sites to unlock the potential of healthcare data [5] - The company’s iRWD™ platform supports various sectors, including rare diseases, oncology, and cardiology, delivering insights that drive innovation in patient care and healthcare disruption [5][6] - Beyond healthcare, OneMedNet's AI technology anonymizes data for other industries such as finance and retail, enabling secure data sharing and project de-risking [6]

Core Insights - HealthVerity has integrated OneMedNet's regulatory-grade imaging Real-World Data (iRWD) into its HealthVerity Marketplace, enhancing the availability of advanced imaging data for life sciences research [1][3] - The integration includes data from over 1,400 healthcare systems and provider sites, encompassing more than 121 million clinical exams from 31 million unique patients, providing valuable insights beyond structured data [2][4] - This collaboration aims to improve the depth of real-world data available to clients, facilitating informed clinical development and commercialization decisions [3][4] Company Overview - HealthVerity is a leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data [4] - OneMedNet Corporation specializes in unlocking the value of regulatory-grade imaging real-world data through its iRWD platform, ensuring secure and privacy-compliant access to extensive imaging datasets [5]